Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

8 terminated/withdrawn out of 56 trials

Success Rate

76.5%

-10.0% vs industry average

Late-Stage Pipeline

13%

7 trials in Phase 3/4

Results Transparency

27%

7 of 26 completed trials have results

Key Signals

9 recruiting7 with results4 withdrawn

Enrollment Performance

Analytics

N/A
28(56.0%)
Phase 2
8(16.0%)
Phase 4
7(14.0%)
Phase 1
6(12.0%)
Early Phase 1
1(2.0%)
50Total
N/A(28)
Phase 2(8)
Phase 4(7)
Phase 1(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (56)

Showing 20 of 56 trials
NCT07218757Not ApplicableRecruiting

Phase 1 Pilot of a Pragmatic Trial of EAET for Veterans With Chronic Pain

Role: collaborator

NCT05467748Phase 1Recruiting

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Role: collaborator

NCT03900754Phase 2Terminated

A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia

Role: collaborator

NCT05120635Not ApplicableRecruiting

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

Role: collaborator

NCT05008198Active Not Recruiting

Assessing an EEG Biomarker of Response to TMS for Major Depression

Role: collaborator

NCT07216222Not ApplicableEnrolling By Invitation

K08 VR Fear Conditioning

Role: collaborator

NCT06110091Not ApplicableRecruiting

Multi-center Trial to Improve Nocturia and Sleep in Older Adults

Role: collaborator

NCT07031245Not ApplicableRecruiting

Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

Role: lead

NCT04087291Not ApplicableCompleted

Veterans Response to Dosage in Chiropractic Therapy

Role: collaborator

NCT05913999Enrolling By Invitation

Serial PET MPI in Patients Undergoing Cancer Treatment

Role: collaborator

NCT03856879Not ApplicableCompleted

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

Role: collaborator

NCT04390880Phase 2Completed

18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer

Role: lead

NCT06932289Not ApplicableNot Yet Recruiting

Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions

Role: lead

NCT05452031Not ApplicableRecruiting

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

Role: collaborator

NCT06039865Not ApplicableCompleted

Chronic Care Management With Wearable Devices in Patients Prescribed Positive Airway Pressure Therapy (mPAP) Trial

Role: lead

NCT06706921Phase 4Recruiting

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Role: lead

NCT05001165Not ApplicableCompleted

Dashboard Activated Services and Tele-Health for Heart Failure

Role: lead

NCT03065465Not ApplicableUnknown

Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage

Role: collaborator

NCT04152993Early Phase 1Recruiting

Responsive Neurostimulation for Post-Traumatic Stress Disorder

Role: lead

NCT04552860Not ApplicableCompleted

vEAET for Older Veterans With Chronic Musculoskeletal Pain Pilot

Role: lead